IMMUNOGEN INC (193) | Intellectual Property (3)
- License Agreements (3 contracts)
- License and Option Agreement dated as of February 28, 2023 by and between ImmunoGen, Inc. and Vertex Pharmaceuticals Incorporated (Filed With SEC on April 28, 2023)
- License Agreement dated as of February 14, 2022 by and between the Registrant and Eli Lilly and Company (Filed With SEC on May 6, 2022)
- Development and License Agreement with Biogen Idec., Inc. dated October 1, 2006 (Filed With SEC on February 28, 2022)
